In terms of mechanism, several studies have found that CVBD, through the CTHRC1-AKT/ERK-Snail pathway or EGFR-FAK-AKT/ERK1/2-Slug pathway, inhibit cancer tumorigenesis through CVBD inducing mitochondrial apoptosis in cancer cells. Here, PTK2 is linked to cancer.